Myotonic disorders in childhood: Diagnosis and treatment

Journal of Child Neurology

Volumn 12, Issue 2, 1997, Pages 116-129

  Moxley III, Richard T ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; BARBITURIC ACID DERIVATIVE; CHLORIDE CHANNEL; HUMAN GROWTH HORMONE; MEXILETINE; MUSCLE RELAXANT AGENT; NEUROMUSCULAR DEPOLARIZING AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PHENYTOIN; QUININE; SODIUM CHANNEL; TESTOSTERONE; THIAZIDE DIURETIC AGENT; TOCAINIDE;

CATARACT; CLINICAL FEATURE; CONFERENCE PAPER; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ENDOCRINE DISEASE; GENETIC DISORDER; HEART ARRHYTHMIA; HUMAN; MATERNAL DISEASE; MYOPATHY; MYOTONIA; MYOTONIC DYSTROPHY; PERIODIC PARALYSIS; PRIORITY JOURNAL; SURGICAL RISK; THOMSEN DISEASE; ARTICLE; CHILD; GENETIC COUNSELING; GENETICS; PRACTICE GUIDELINE;

CHILD; DIAGNOSIS, DIFFERENTIAL; GENETIC COUNSELING; GUIDELINES; HUMANS; MYOTONIA; MYOTONIA CONGENITA; MYOTONIC DYSTROPHY;

EID: 0031068689     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/088307389701200208     Document Type: Conference Paper

References (56)

1. Ptáček LJ, Johnson KJ, Griggs RC: Genetics and physiology of the myotonic muscle disorders. N Engl J Med 1993:328:482-489.
2. Meyer-Kleine C, Steinmeyer K, Ricker K, et al: Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCN 1) leading to myotonia. Am J Hum Genet 1995;57:1325-1334.
3. Trudell RG, Kaiser KK, Griggs RC: Acetazolamide responsive myotonia congenita. Neurology 1987;37:488-491.
4. Ptáček LJ, Tawil R, Griggs RC, et al: Sodium channel mutations in acetazolamide-responsive myotonia congenita, paramyotonia congenita, and hyperkalemic periodic paralysis. Neurology 1994;44:1500-1503.
5. Lerche H, Heine R, Pika U, et al: Human sodium channel myotonia: Slowed channel inactivation due to substitutions for a glycine within the III-IV linker. J Physiol 1993;470:13-22.
6. Ricker KW, Moxley RT: Myotonia fluctuans. A third type of muscle sodium channel disease. Ann Neurol 1994;51:1095-1102.
7. Moxley RT III: Myotonic muscular dystrophy, in Rowland LP (ed): Handbook of Clinical Neurology, vol. 18. Amsterdam, Elsevier, 1992, pp 209-259.
8. Harper PS: Myotonic Dystrophy, 2nd ed. London, Saunders, 1989.
9. Thornton CA, Griggs RC, Moxley RT Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol 1994;35:269-272.
10. Ricker K, Koch MC, Lehmann-Horn F, et al: Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 1994;44:1448-1452.
11. Ricker K, Koch MC, Lehmann-Horn F, et al: Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol 1995;52:25-31.
12. Moxley RT III: Proximal myotonic myopathy, a recently delineated autosomal dominant disorder. Neuromusc Disord 1996;6:87-93.
13. Dyken PR, Harper PS: Congenital dystrophia myotonica. Neurology 1973;23:465-473.
14. Brook JD, McCurrach ME, Harley HG, et al: Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 1992;68:799-808.
15. Fu YH, Pizzuti A, Fenwick RG Jr, et al: An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992;255:1256-1258.
16. Mahadevan M, Tsilfidis C, Sabourin L, et al: Myotonic dystrophy mutation: An unstable CTG repeat in the 3′ untranslated region of the gene. Science 1992;255:1253-1255.
17. Redman JB, Fenwick RG, Fu YH, et al: Relationship between parental trinucleotide CTG repeat length and severity of myotonic dystrophy in offspring. JAMA 1993;269:1960-1965.
18. Harley HG, Rundle SA, MacMillan JC, et al: Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet 1998;52:1164-1174.
19. Lavedan C, Hofmann-Radvanyi H, Shelbourne P, et al: Myotonic dystrophy: Size and sex-dependent dynamics of CTG meiotic instability, and somatic mosaicism. Am J Hum Genet 1993;52:873-883.
20. Tsilfidis C, MacKenzie AE, Mettler G, et al: Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat Genet 1992;1:192-195.
21. Shelbourne P, Davies J, Buxton J, et al: Direct diagnosis of myotonic dystrophy with a disease-specific DNA marker. N Engl J Med 1903;328:471-475.
22. Rudel R, Ruppersberg JP, Spittelmeister W: Abnormalities of the fast sodium current in myotonic dystrophy, recessive generalized myotonia, and adynamia episodica. Muscle Nerve 1989;12:281-287.
23. + channels in myotonic dystrophy. Muscle Nerve 1994;17:1264-1270.
24. Hunter A, Tsilfidis C, Mettler G, et al: The correlation of age of onset with CTG trinucleotide repeat amplification in myotonic dystrophy. J Med Genet 1992;29:774-779.
25. Jansen G, Willems P, Coerwinkel M, et al: Gonosomal mosaicism in myotonic dystrophy patients: Involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm. Am J Hum Genet 1994;54:575-585.
26. Brunner HG, Bruggenwirth HT, Nillesen W: Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM). Am J Hum Genet 1993;58:1016-1023.
27. Ashizawa T, Anvret M, Baiget M: Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet 1994;54:414-423.
28. Ashizawa T, Dubel JR, Harati Y: Somatic instability of CTO repeat in myotonic dystrophy. Neurology 1993;43:2674-2678.
29. Anvret M, Ahlberg G, Grandell U, et al: Larger expansions of the CTG repeat in muscle compared to lymphocytes from patients with myotonic dystrophy. Hum Mol Genet 1993;2:1397-1400.
30. Thornton CA, Johnson K, Moxley RT III: Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leucocytes. Ann Neurol 1994;35:104-107.
31. Neville CE, Mahadevan MS, Barcelo JM, et al: High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation. Hum Mol Genet 1994;3:45-51.
32. Lavedan C, Hofmann-Radvanyi H, Boileau C, et al: French myotonic dystrophy families show expansion of a CTG repeat in complete linkage disequilibrium with an intragenic 1 kb insertion. J Med Genet 1994;31:33-36.
33. Shaw DJ, McCurrach M, Rundle SA, et al: Genomic organization and transcriptional units at the myotonic dystrophy locus. Genomics 1993;18:673-679.
34. Fu YH, Friedman DL, Richards S, et al: Varying expression of myotonin-protein kinase mRNA and protein levels in the adult form of myotonic dystrophy. Science 1993;72:971-983.
35. Griggs RC, Pandya S, Florence JM, et al: Randomized controlled trial of testosterone in myotonic dystrophy. Neurology 1989;39:219-222.
36. Thornton CA, Griggs RC, Welle S, et al: Recombinant human growth hormone (rHGH) treatment increases lean body mass in patients with myotonic dystrophy, abstract. Neurology 1993;43:A280.
37. Koch MC, Steinmeyer K, Lorenz C, et al: The skeletal muscle chloride channel in dominant and recessive human myotonia. Science 1992;257:797-800.
38. Abdalla JA, Casley WL, Cousin HK, et al: Linkage of Thomsen disease to the T-cell receptor beta (TCRB) locus on chromosome 7q35. Am J Hum Genet 1992;51:579-584.
39. George AL, Crackower MA, Abdalla JA, et al: Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita). Nat Genet 1993;3:305-310.
40. Koch MC, Ricker K, Otto M, et al: Evidence for genetic homogeneity in autosomal recessive generalised myotonia (Becker). J Med Genet 1993;30:914-917.
41. Koty PP, Marks HG, Turel A, et al: Linkage and mutation analysis of Thomsen and Becker myotonia families, abstract, Am J Hum Gen 1994;55(Suppl):227.
42. Streib EW: AAEM Minimonograph #27: Differential diagnosis of myotonic syndromes. Muscle Nerve 1987;10:603-615.
43. Rüdel R, Lehmann-Horn F, Ricker K: Altered excitability of the muscle cell membrane. The nondystrophic myotonias, in Engel AG, Franzini-Armstrong C (eds): Myology. New York, McGraw-Hill, pp 1291-1302.
44. Zwarts MJ, VanWeerden TW: Transient paresis in myotonic syndromes. Brain 1989;112:665-680.
45. Crew J, Kaiswer KK, Brooke MH: Muscle pathology of myotonia congenita. J Neurol Sci 1076;28:440-457.
46. Lipicky RJ, Bryant SH: A biophysical study of the human myotonias, in Desmedt JE (ed): New Developments in Electromyography and Clinical Neurophysiology. Basel, Switzerland, S Karger, 1993, pp 451-463.
47. Ricker K, Lehmann-Horn F, Moxley RT III: Myotonia fluctuans. Arch Neurol 1990;47:268-272.
48. Munsat TL: Therapy of myotonia. A double-blind evaluation of diphenylhydantoin, procainamide, and placebo. Neurology 1967;17:359-367.
49. Kwiecinski H, Ryniewicz B, Ostrzycki A: Treatment of myotonia with antiarrhythmic drugs. Acta Neurol Scand 1992;86:371-375.
50. Ceccarelli M, Rossi B, Sicilino G, et al: Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletine. Acta Paediatr 1992;81:453-455.
51. Ptáček LJ, Tawil R, Griggs RC, et al: Linkage of atypical myotonia congenita to a sodium channel locus. Neurology 1992;42:431-433.
52. Soff GA, Kadin ME: Tocainide-induced reversible agranulocytosis and anemia. Arch Intern Med 1987;147:598-599.
53. Plassart E, Reboul J, Rime CS, et al: Mutations in the muscle sodium channel gene (SCN4A) in 13 French families with hyperkalemic periodic paralysis and paramyotonia congenita: Phenotype to genotype correlations and demonstrations of the predominance of two mutations. Eur J Hum Genet 1994;2:110-124.
54. Riggs JE, Griggs RC: The diagnosis and treatment of the periodic paralyses, in Klawans HL (ed): Clinical Neuropharmacology, New York, Raven Press, 1979, pp 123-138.
55. Ptáček LJ, George AL, Griggs RC, et al: Identification of a mutation in the gene causing hyperkalemic periodic paralysis. Cell 1991;67:1021-1027.
56. + channel α-subunit in hyperkalemic periodic paralysis. Nature 1991;354:387-389.